James Lovgren
Corporate Officer/Principal chez Seaport Diagnostics, Inc.
Profil
James Lovgren is currently the Chief Business Officer at Seaport Diagnostics, Inc. Prior to this, he held positions as the General Manager-Cell & Gene Therapy at Thermo Fisher Scientific, Inc., Vice President-Cell Therapy at Berkeley Lights, Inc., and Senior Vice President-Global Marketing at MaxCyte, Inc. He holds an MBA from North Carolina State University and an undergraduate degree from the University of North Florida.
Postes actifs de James Lovgren
| Sociétés | Poste | Début |
|---|---|---|
Seaport Diagnostics, Inc.
 Seaport Diagnostics, Inc. BiotechnologyHealth Technology Seaport Diagnostics, Inc. operates as a biotechnology company which develops treatments for genetically inherited diseases. It also offers DNA Tests for consumers across many categories such as nutrition, fitness, behavior tendencies, skincare, and more; provides consumers access to genetic information via mobile application; and manages human cell bank for future testing on regenerative medical therapies. The company was founded by Scott Schaus, Robin Y. Smith and Kate Blanchard on June 30, 2014 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
Anciens postes connus de James Lovgren
| Sociétés | Poste | Fin |
|---|---|---|
| MAXCYTE, INC. | Sales & Marketing | 01/10/2023 |
| THERMO FISHER SCIENTIFIC | Corporate Officer/Principal | - |
Berkeley Lights, Inc.
 Berkeley Lights, Inc. Packaged SoftwareTechnology Services Berkeley Lights, Inc. engages in rapid development and commercialization of biotherapeutics and other cell-based products. Its platform captures deep phenotypic, functional and genotypic information for tens of thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. It operates through the following geographical segments: North America, Asia Pacific, and Europe. The company was founded by Igor Y. Khandros, William H. Davidow, Michael E. Marks, and Ming C. Wu on April 5, 2011 and is headquartered in Emeryville, CA. | Corporate Officer/Principal | - |
Formation de James Lovgren
| North Carolina State University | Masters Business Admin |
| University of North Florida | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MAXCYTE, INC. | Health Technology |
| THERMO FISHER SCIENTIFIC | Health Technology |
| Entreprise privées | 2 |
|---|---|
Seaport Diagnostics, Inc.
Seaport Diagnostics, Inc. BiotechnologyHealth Technology Seaport Diagnostics, Inc. operates as a biotechnology company which develops treatments for genetically inherited diseases. It also offers DNA Tests for consumers across many categories such as nutrition, fitness, behavior tendencies, skincare, and more; provides consumers access to genetic information via mobile application; and manages human cell bank for future testing on regenerative medical therapies. The company was founded by Scott Schaus, Robin Y. Smith and Kate Blanchard on June 30, 2014 and is headquartered in Boston, MA. | Health Technology |
Berkeley Lights, Inc.
Berkeley Lights, Inc. Packaged SoftwareTechnology Services Berkeley Lights, Inc. engages in rapid development and commercialization of biotherapeutics and other cell-based products. Its platform captures deep phenotypic, functional and genotypic information for tens of thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. It operates through the following geographical segments: North America, Asia Pacific, and Europe. The company was founded by Igor Y. Khandros, William H. Davidow, Michael E. Marks, and Ming C. Wu on April 5, 2011 and is headquartered in Emeryville, CA. | Technology Services |
